On similar note, if we can get solid BE for Concerta that is going to pass muster with FDA after Concerta generics were pulled, it will be a similar position as among first with Generic OxyContin. I believe this was referred to when Nasrat said a pilot or BE study will be done in the fall or next year depending on bed availability and other factors.
News 
Market Data 
Discover 
